Search

everythinglearnresearchcommunity

for

Search:↓

Removing STAT5 from 3D-cultured human skin cells reduces their ability to grow hair.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Estrogen increases a growth factor in hair cells which might affect hair loss.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Some skin diseases may indicate a higher risk of metabolic syndrome and related health issues.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Stress can stop hair growth in mice, and treatments can reverse this effect.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Icariin helps mouse hair grow by boosting a growth factor in skin cells.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Permanent hair dye mixtures can irritate and damage the skin.

Burn scars heal abnormally and more research is needed to find better treatments.